manilatimes.net·3 min read·hard
CancerVax Achieves Major Milestone in Activating Human Killer T-Cells Against Cancer
✦AI Summary
CancerVax, Inc. announced that its experimental therapy successfully activated human antiviral Killer T-cells in in-vitro studies. The platform uses 'Smart mRNA' to disguise cancer cells as viral infections, triggering the body's immune system to attack them.
In-vitro studies confirmed that the Company’s revolutionary therapy successfully disguised liver cancer cells as virally infected cells and activated pre-existing human antiviral Killer T-cells
sciencehealth
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in